Discover the top 25 companies transforming the radiotherapy market, including Siemens Healthineers AG, Elekta, Accuray Incorporated, and other industry leaders. Backed by a market projected to grow from $7.21B to $9.62B by 2030 at a CAGR of 4.9%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Radiotherapy Companies

Siemens Healthineers AG (Varian Medical Systems, Inc.)

Siemens Healthineers, through its Varian subsidiary, is a global leader in radiotherapy, providing a comprehensive ecosystem of hardware and software solutions including the TrueBeam and Halcyon linear accelerators. The company focuses on “Intelligent Cancer Care,” leveraging artificial intelligence and machine learning to optimize treatment planning and adaptive therapy. With a dominant market share in external beam radiation therapy and a growing presence in proton therapy with the ProBeam system, Siemens Healthineers is a primary driver of technological integration and precision oncology worldwide.

Elekta

Elekta is a pioneering Swedish medical technology company specializing in precision radiation medicine and neuroscience. The company offers a diverse portfolio including the Versa HD linear accelerator, the Leksell Gamma Knife for stereotactic radiosurgery, and the Unity MR-Linac, which combines high-field MRI with radiation delivery for real-time adaptive treatment. Elekta maintains a strong global presence, particularly in Europe and emerging markets, and focuses on expanding access to advanced cancer care through its integrated oncology informatics and strategic social initiatives.

Accuray Incorporated

Accuray Incorporated is a specialized developer of innovative radiation oncology systems designed to deliver highly conformal and precise treatments. Its flagship platforms, the CyberKnife and TomoTherapy systems, are recognized for their unique robotic guidance and integrated helical delivery capabilities, allowing for sub-millimeter accuracy in treating complex tumors. Accuray focuses on advancing adaptive radiotherapy and real-time motion management, positioning itself as a leader in stereotactic body radiation therapy (SBRT) and personalized treatment modules.

IBA Worldwide

IBA (Ion Beam Applications) is the global leader in particle therapy technology, specializing in the development of proton and carbon ion therapy systems for highly targeted cancer treatment. The company’s ProteusPLUS and ProteusONE platforms are designed to maximize clinical efficiency while minimizing damage to healthy surrounding tissue. IBA also provides integrated dosimetry and radiopharmaceutical solutions, maintaining a dominant position in the expanding market for advanced particle therapy centers and next-generation radiation accelerators.

ViewRay, Inc.

ViewRay is a technology leader that revolutionized the industry with the introduction of MRI-guided radiation therapy (MRgRT). Its MRIdian system integrates real-time magnetic resonance imaging with radiation delivery, allowing clinicians to visualize soft-tissue movement and adapt treatment plans while the patient is on the table. This capability enhances precision for abdominal and pelvic tumors, reducing treatment margins and toxicity while supporting the industry’s shift toward personalized, image-guided cancer care.

Perspective Therapeutics

Perspective Therapeutics is an innovative medical technology firm focused on developing advanced radiation oncology solutions that improve precision and accessibility. The company specializes in the design of compact and integrated treatment systems that aim to democratize advanced radiotherapy capabilities for underserved healthcare markets. By focusing on cost-effective engineering and simplified workflows, Perspective Therapeutics addresses the global need for scalable cancer care infrastructure and efficient localized treatment delivery.

Hitachi Ltd. (Hitachi High-Tech Corporation)

Hitachi is a major industrial conglomerate that provides high-performance radiotherapy solutions, particularly in the field of proton beam therapy. Leveraging its extensive engineering expertise in particle acceleration and superconducting magnets, Hitachi delivers comprehensive treatment systems integrated with advanced digital imaging and treatment planning software. The company’s systems are utilized by leading medical institutions globally, emphasizing reliability, precision, and the advancement of heavy-ion therapy technologies.

Sumitomo Heavy Industries, Ltd.

Sumitomo Heavy Industries is a key player in the particle therapy market, specializing in the manufacturing of advanced cyclotrons and beam delivery systems for proton therapy. The company focuses on developing compact and efficient accelerator designs that reduce the footprint and cost of particle therapy centers, facilitating broader global adoption. Sumitomo’s commitment to precision engineering and continuous innovation supports the delivery of high-quality radiation treatment for complex oncological cases.

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a leading international medical technology company that provides specialized solutions for intraoperative radiation therapy (IORT). Its INTRABEAM system allows for the delivery of targeted low-energy X-rays directly to the tumor bed during surgery, particularly for breast cancer, reducing the need for lengthy post-operative external beam sessions. Zeiss focuses on integrating high-precision optics and miniaturized radiation sources to enhance surgical outcomes and patient convenience in localized cancer treatment.

MIM Software Inc.

MIM Software Inc. is a prominent provider of vendor-neutral medical imaging software used extensively in radiation oncology for treatment planning and image fusion. The company’s solutions enable clinicians to integrate data from PET, CT, and MRI scans to improve tumor contouring and treatment precision. Recently acquired by GE HealthCare, MIM Software focuses on advancing AI-driven automation and quantitative imaging tools that streamline clinical workflows and support data-driven decision-making in complex radiotherapy environments.

Panacea Medical Technologies Pvt. Ltd.

Panacea Medical Technologies is an Indian-based manufacturer of advanced radiotherapy equipment, focused on providing high-quality, affordable cancer treatment solutions. The company offers a range of products including the Siddharth linear accelerator and Bhabhatron cobalt-60 teletherapy units, which are designed to withstand the operational challenges of emerging markets. Panacea’s focus on robust engineering and cost-effective technology plays a critical role in expanding cancer care access in underserved regions across Asia and Africa.

Provision Healthcare

Provision Healthcare is a comprehensive cancer care provider and technology developer specializing in proton therapy solutions. The company operates through an integrated model that includes clinical centers, manufacturing, and training, utilizing its proprietary ProNova SC360 proton therapy system. Provision focuses on advancing compact, high-precision delivery systems that utilize pencil-beam scanning technology, aiming to make proton therapy more commercially viable and clinically accessible for regional healthcare networks.

Mevion Medical Systems

Mevion Medical Systems is a leading provider of compact proton therapy systems designed for seamless integration into existing radiation oncology departments. Its MEVION S250 series utilizes a unique gantry-mounted synchrocyclotron, significantly reducing the size, cost, and complexity traditionally associated with particle therapy. Mevion focuses on providing high-quality pencil-beam scanning and adaptive capabilities, enabling hospitals to offer advanced proton treatments with a footprint similar to a standard linear accelerator.

Koninklijke Philips N.V.

Philips is a global leader in health technology that provides critical imaging and software support for the radiotherapy market. The company offers specialized CT, MRI, and PET/CT simulators designed for precise treatment planning and tumor characterization. Through its focus on “Smart Systems” and oncology informatics, Philips integrates diagnostic imaging with radiation therapy workflows, facilitating multi-disciplinary collaboration and the adoption of personalized, image-guided treatment strategies.

Shinva Medical Instrument Co., Ltd.

Shinva Medical Instrument is a major Chinese manufacturer of medical equipment, including a wide array of radiotherapy systems such as linear accelerators and cobalt-60 units. As a key player in the Asia-Pacific market, Shinva provides integrated solutions for oncology departments, ranging from treatment delivery systems to sterilization and imaging equipment. The company emphasizes large-scale manufacturing and R&D to meet the growing demand for domestic cancer care infrastructure in China and surrounding international markets.

Brainlab AG

Brainlab is a German digital medical technology company that specializes in software-driven solutions for high-precision radiotherapy and radiosurgery. Its ExacTrac Dynamic system is a market leader in patient positioning and monitoring, utilizing surface tracking and thermal imaging to ensure sub-millimeter accuracy during treatment. Brainlab focuses on vendor-neutral software that integrates with various linear accelerators, advancing the fields of stereotactic radiosurgery (SRS) and digital oncology through AI-supported automation.

RaySearch Laboratories

RaySearch Laboratories is a prominent Swedish medical technology company that develops advanced software for radiation therapy planning. Its flagship product, RayStation, is a vendor-neutral treatment planning system (TPS) that supports a wide range of treatment modalities, including photon, electron, and particle therapy. RaySearch is recognized for its innovative features such as multi-criteria optimization, machine learning-based contouring, and automated planning, which help clinics improve efficiency and treatment quality.

Optivus Proton Therapy, Inc.

Optivus Proton Therapy is a specialized provider of proton beam therapy systems, building on a legacy of pioneering clinical research in particle therapy. The company provides comprehensive, large-scale proton therapy solutions designed for multi-room clinical centers, focusing on high-reliability synchrotron technology. Optivus emphasizes the integration of advanced imaging and patient transport systems to deliver precise radiation doses while maintaining high patient throughput for major academic and clinical institutions.

Bebig Medical

Bebig Medical is a global specialist in brachytherapy technology, providing high-quality solutions for the internal delivery of radiation. The company offers a comprehensive range of products, including high-dose-rate (HDR) afterloaders, specialized applicators, and treatment planning software for various cancer types, such as cervical and prostate cancer. Bebig focuses on enhancing clinical precision and safety in brachytherapy, supporting healthcare providers with reliable, cost-effective systems for targeted internal radiation treatment.

P-Cure

P-Cure is an innovative developer of compact, upright proton therapy systems designed to improve patient comfort and clinical efficiency. Their technology allows patients to be treated in a seated position, which can enhance organ stability and reduce the overall footprint of the treatment room compared to traditional gantries. P-Cure focuses on making proton therapy more accessible to community-based oncology clinics by providing high-quality, cost-effective systems that can be installed in standard LINAC vaults.

Theragenics Corporation

Theragenics Corporation is a leading manufacturer of specialized medical devices for the brachytherapy market, primarily known for its radioactive seeds used in the treatment of prostate cancer. The company provides a range of palladium-103 and iodine-125 isotopes, alongside various delivery systems and accessories. Theragenics focuses on maintaining high-purity manufacturing and a reliable supply chain to support urologists and radiation oncologists in delivering precise, minimally invasive internal radiation therapy.

Protom International

Protom International is a medical technology company specializing in the development of compact and efficient proton therapy solutions. Its Radiance 330 system utilizes a small-footprint synchrotron to deliver high-precision pencil-beam scanning, designed to fit into existing clinical environments with lower capital and operational costs. Protom focuses on providing flexible, modular systems that enable healthcare institutions to scale their particle therapy capabilities according to patient demand and budgetary requirements.

DOSIsoft SA

DOSIsoft is a French software company that develops advanced solutions for radiotherapy treatment planning and quality assurance (QA). Their products include specialized modules for patient-specific dosimetry, image-guided radiotherapy (IGRT), and molecular imaging. DOSIsoft focuses on providing vendor-independent software that enhances the accuracy and safety of radiation delivery, helping clinical teams optimize treatment protocols and verify dose distributions across various delivery platforms.

IsoAid, LLC

IsoAid is a leading American manufacturer of brachytherapy seeds and delivery systems, specializing in the production of high-quality iodine-125 and cesium-131 sources. The company provides customized solutions for the treatment of prostate, lung, and ocular cancers, emphasizing rapid turnaround times and precision loading for clinical procedures. IsoAid focuses on supporting radiation oncology practices with reliable isotopes and specialized accessories that ensure the accurate placement and dosing of internal radiation.

MagnetTx Oncology Solutions Ltd.

MagnetTx Oncology Solutions is a Canadian medical technology company that developed the Aurora-RT, an innovative linear accelerator integrated with a 0.5T open-view MRI. This system is designed to provide real-time, high-contrast imaging of tumors and surrounding organs during treatment, enabling advanced adaptive radiotherapy. MagnetTx focuses on improving the visualization of soft-tissue targets, allowing for smaller margins and more precise radiation delivery, particularly for cancers in the lung, liver, and pancreas.

Download PDF Brochure:“Click Here”